Tissue factor as a novel marker for detection of circulating cancer cells

References

• Adamson AS, Luckert P, Pollard M, Snell ME, Amirkhosravi M, Francis JL. (1994). Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer. Br J Cancer 69(2):286–90.
   PubMedGoogle Scholar
• Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W. (2004). Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10(5):502–9.
   PubMedGoogle Scholar
• Boccaccio C, Comoglio PM. (2005). A functional role for hemostasis in early cancer development. Cancer Res 65(19):8579–82.
   PubMedGoogle Scholar
• Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. (2003). Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9(4):458–62.
   PubMedGoogle Scholar
• Breitenstein A, Tanner FC, Lüscher TF. (2010). Tissue factor and cardiovascular disease: quo vadis? Circ J 74(1):3–12.
   PubMedGoogle Scholar
• Rivers RP, Hathaway WE, Weston WL. (1975). The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3):311–6.
   PubMedGoogle Scholar
• Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A.(1995). Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 92(18):8205–9.
   PubMedGoogle Scholar
• Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH. (1999). Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 82(1):88–92.
   PubMedGoogle Scholar
• Callander N, Rapaport SI. (1996). Trousseau’s syndrome. West J Med 158(4):364–71.
   Google Scholar
• Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. (2008). Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149(5):323–33.
   PubMedGoogle Scholar
• Chand HS, Ness SA, Kisiel W. (2006). Identification of a novel human tissue factor splice variant that is upregulated in tumour cells. Int J Cancer 118(7):1713–20.
   PubMedGoogle Scholar
• Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. (1999). Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94(10):3413–20.
   PubMedGoogle Scholar
• Drake TA, Morrissey JH, Edgington TS. (1989). Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134(5):1087–97.
   PubMedGoogle Scholar
• Edgington TS, Mackman N, Fan ST, Ruf W. (1992). Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Hematol 34 Suppl:S15–27.
   Google Scholar
• Fleck RA, Rao LV, Rapaport SI, Varki N. (1990). Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59(2):421–37.
   PubMedGoogle Scholar
• Gabri MR, Vazquez V, Girón S, Castro MA, Cinat G, Gomez RE, Santoro FM, Gomez DE, Alonso DF. (2008). Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients. Int J Mol Med 21(5):555–9.
   PubMedGoogle Scholar
• Gilbey AM, Burnett D, Coleman RE, Holen I. (2004). The detection of circulating breast cancer cells in blood. J Clin Pathol 57(9):903–11.
   PubMedGoogle Scholar
• Goldin-Lang P, Tran QV, Fichtner I, Eisenreich A, Antoniak S, Schulze K, Coupland SE, Poller W, Schultheiss HP, Rauch U. (2008). Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumour metastasis. Oncol Rep 20(1):123–8.
   PubMedGoogle Scholar
• Guthmann MD, Castro MA, Cinat G, Venier C, Koliren L, Bitton RJ, Vázquez AM, Fainboim L. (2006). Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients. J Immunother 29(2):215–23.
   PubMedGoogle Scholar
• Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. (1996). Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77(9):1877–83.
   PubMedGoogle Scholar
• Jółkowska J, Derwich K, Dawidowska M. (2007). Methods of minimal residual disease (MRD) detection in childhood haematological malignancies. J Appl Genet 48(1):77–83.
   PubMedGoogle Scholar
• Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. (1999). Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat 55(2):127–36.
   PubMedGoogle Scholar
• Koomägi R, Volm M. (1998). Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 79(1):19–22.
   PubMedGoogle Scholar
• Levi M, Keller TT, van Gorp E, ten Cate H. (2003). Infection and inflammation and the coagulation system. Cardiovasc Res 60(1):26–39.
   PubMedGoogle Scholar
• Levi M, van der Poll T, ten Cate H. (2006). Tissue factor in infection and severe inflammation. Semin Thromb Hemost 32(1):33–9.
   PubMed Web of Science ®Google Scholar
• Li C, Colman LM, Collier ME, Dyer CE, Greenman J, Ettelaie C. (2006). Tumour-expressed tissue factor inhibits cellular cytotoxicity. Cancer Immunol Immunother 55(11):1301–8.
   PubMedGoogle Scholar
• Mackman N, Morrissey JH, Fowler B, Edgington TS. (1989). Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 21;28(4):1755–62.
   Google Scholar
• Mackman N. (2007). Alternatively spliced tissue factor - one cut too many? Thromb Haemost 97(1):5–8.
   PubMedGoogle Scholar
• Mackman N. (2009). The many faces of tissue factor. J Thromb Haemost 7 Suppl 1:136–9.
   PubMedGoogle Scholar
• Mackman N. (2009). The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 108(5):1447–52.
   PubMedGoogle Scholar
• Milsom C, Rak J. (2008). Tissue factor and cancer. Pathophysiol Haemost Thromb 36(3-4):160–76.
   PubMedGoogle Scholar
• Mueller BM, Reisfeld RA, Edgington TS, Ruf W. (1992). Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A 89(24):11832–6.
   PubMedGoogle Scholar
• Osterud B, Bjørklid E. (1982). The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol 29(2):175–84.
   PubMedGoogle Scholar
• Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Hu Z, Barney KA, Degen JL. (2007). Tumour cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 110(1):133–41.
   PubMedGoogle Scholar
• Pipinikas CP, Nair SB, Kirby RS, Carter ND, Fenske, CD (2007) Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers 12(5):541–557.
   PubMedGoogle Scholar
• Rickles FR, Levine MN. (2001). Epidemiology of thrombosis in cancer. Acta Haematol 106(1-2):6–12.
   PubMedGoogle Scholar
• Rivers RP, Hathaway WE, Weston WL. (1975). The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3):311–6.
   PubMedGoogle Scholar
• Ruf W, Yokota N, Schaffner F. (2010). Tissue factor in cancer progression and angiogenesis. Thromb Res 125 Suppl 2:S36–8.
   Google Scholar
• Sato T, Tsujino I, Ikeda D, Ieko M, Nishimura M. (2006). Trousseau’s syndrome associated with tissue factor produced by pulmonary adenocarcinoma. Thorax 61(11):1009–10.
   PubMedGoogle Scholar
• Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, Yakumaru K, Yoshizawa Y. (1999). Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 79(3-4):472–7.
   PubMedGoogle Scholar
• Scarpati EM, Wen D, Broze GJ Jr, Miletich JP, Flandermeier RR, Siegel NR, Sadler JE. (1987). Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 26(17):5234–8.
   PubMedGoogle Scholar
• Semeraro N, Colucci M. (1997). Tissue factor in health and disease. Thromb Haemost 78(1):759–64.
   PubMedGoogle Scholar
• Varki A. (2007). Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 110(6):1723–9.
   PubMedGoogle Scholar
• Vázquez V, Otero LL, Laurent VE, Gabri MR, Gómez DE, Alonso DF. (2009) Molecular detection of minimal residual disease in melanoma and solid tumors. Medicina (B Aires).69 (1 Pt 2):181–90.
   PubMedGoogle Scholar
• Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ. (2004). Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 10(1-6):6–11.
   PubMedGoogle Scholar
• Wilcox JN, Smith KM, Schwartz SM, Gordon D. (1989). Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 86(8):2839–43.
   PubMedGoogle Scholar
• Zacharski LR, Schned AR, Sorenson GD. (1983). Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res 43(8):3963–8.
   PubMedGoogle Scholar